STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Avalo Therapeutics, Inc.

Filed

December 12, 2025

Period of Report

December 10, 2025

Accession Number

0001470831-25-000412